Michel Vounatsos Biogen Inc. (BIIB) insider trading activity

Michel Vounatsos is Chief Executive Officer of BIOGEN INC.. Currently has a direct ownership of 67,261 shares of BIIB, which is worth approximately $13.6 Million. The most recent transaction as insider was on Feb 18, 2022, when has been sold 2,746 shares (Common Stock) at a price of $209.79 per share, resulting in proceeds of $576,083. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.3K

0% 3M change

0% 12M change

Total Value Held $13.6 Million

Michel Vounatsos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2022	SELL Payment of exercise price or tax liability	$576,083 $209.79 p/Share	2,746 Reduced 3.92%	67,261 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	6,191 Added 8.12%	70,007 Common Stock
Feb 12 2022	SELL Payment of exercise price or tax liability	$1,838,178 $214.59 p/Share	8,566 Reduced 11.83%	63,816 Common Stock
Feb 12 2022	BUY Exercise of conversion of derivative security	-	8,716 Added 11.01%	70,465 Common Stock
Jan 19 2022	BUY Grant, award, or other acquisition	-	10,594 Added 14.27%	63,666 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$4,023,928 $278.03 p/Share	14,473 Reduced 21.46%	52,969 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	-	16,289 Added 21.3%	60,194 Common Stock
Jan 27 2021	BUY Grant, award, or other acquisition	-	16,343 Added 24.21%	51,153 Common Stock
Nov 30 2020	BUY Open market or private purchase	$748,061 $241.31 p/Share	3,100 Added 8.18%	34,810 Common Stock

Also insider at

PKI

PERKINELMER INC Healthcare

ZLAB

Zai Lab Ltd Healthcare